Verified peer comparison
Beneficient vs Kymera Therapeutics Financial Comparison
Direct answer
Beneficient and Kymera Therapeutics are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Beneficient email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Beneficient Revenue
- -39,125,000 USD
- Kymera Therapeutics Revenue
- 39,200,000 USD
- Beneficient Operating income
- -79,784,000 USD
- Kymera Therapeutics Operating income
- -349,400,000 USD